WHO consults on public disclosure of clinical trial results
This article was originally published in SRA
The World Health Organization has become the latest entity to take forward ongoing efforts for greater transparency around the conduct of clinical trials by launching a 30-day public consultation on this topic1,2. The public consultation exercise ends on 15 November and will culminate in the WHO issuing an official statement on the public disclosure of clinical trial results.
You may also be interested in...
The World Health Organization’s 2015 standard that specifies strict timelines for reporting clinical trial results is to be implemented by major medical research funders and NGOs in a year’s time.
The European Directorate for the Quality of Medicines & HealthCare is proceeding carefully to find the right balance between serving the diverse requirements of various stakeholders that make use of its ‘certificates of suitability.’
The International Pharmaceutical Regulators Programme has documented various approaches currently being used for the clinical comparability of biosimilar monoclonal antibodies in different jurisdictions.